GSK says Q3 earnings fall 14.4% amid COVID-19 disruption
Drugmaker GlaxoSmithKline says third-quarter earnings fell 14.4% as disruptions caused by the COVID-19 pandemic reduced sales of vaccines, antibiotics and consumer healthcare products ByThe Associated Press October 28, 2020, 12:53 … Read More
![]()

